TGFB1 and myeloid sarcoma: In summary, our results provide evidence for a crosstalk between TGF-β1 and Nrf2 signaling pathways under CNS demyelination, highlighting the importance of the oxidative and inflammatory cellular management in neuroinflammatory-associated diseases such as MS.